Shareholders meeting

Ref: ADL/SE/2026-27/47 September 26, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 BSE CODE – 524348 NSE SYMBOL: AARTIDRUGS Dear Sir/Madam, Sub: Scrutinizer's Report and Voting Result Ref: Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the 41st Annual General Meeting (“AGM”) of the Company which was held on Saturday, September 26, 2026 at 11:00 AM (IST) through Video Conferencing/ Other Audio Visual Means, the shareholders transacted the matters as set out in the Notice convening the AGM. The Shareholders were provided with the facility to vote on the resolutions through remote e- voting and e-voting at the said AGM. In this connection, please find enclosed, the Report of the Scrutinizer dated September 26, 2026, pursuant to Section 108 of the Companies Act, 2013 read with the Companies (Management and Administration) Rules, 2014 and the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”). The Voting Results, as required under Regulation 44 of the Listing Regulations, are also duly provided in the said Scrutinizer’s Report. Kindly take the same on record. Thanking you, Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: F12932 COMPANY SECRETARIES 201-206, Shiv Smriti Chambers, 2nd Floor, 49/A, Dr. Annie Besant Road, Above Corporation Bank, Worli, Mumbai-400 018 Tel.: +91-22-6611 9696. •E-mail: dipti@mehta-mehta.com. •Visit us: www.mehta-mehta.com AUTHORISED AGENTS FOR TRADEMARK, COPYRIGHT AND PATENT E-Voting Report of Scrutinizer [Pursuant to section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014] Date: 25th September, 2026 The Chairman, Aarti Drugs Limited Mahendra Industrial Estate, Ground Floor, Plot No. 109-D, Road No, 29, Sion (E), Mumbai 400022 Dear Sir, 1. I, CS Monali Bhandari, Partner of M/s. Mehta & Mehta, Practicing Company Secretaries, have been appointed by the Board of Directors of Aarti Drugs Limited (the Company) as Scrutinizer for the purpose of thee-voting process and ascertaining the requisite majority one-voting carried out as per the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 (Rules) (as substituted by the Companies (Management and Administration) Amendment Rules, 2015 on the resolutions contained in the notice of 41st Annual General Meeting (AGM) held on 26th September, 2026 together with explanatory statement (hereinafter referred to as 11the Notice"). 2. The management of the Company is responsible to ensure the compliance with the requirements of the Companies Act, 2013 and Rules relating to voting through electronic means on the resolution contained in the notice. My responsibility as a scrutinizer for thee-voting process is restricted to make a scrutinizer's report of the votes cast "in favour" or "against" the resolutions stated in the Notice, based on the reports generated from the e-voting system provided by National Securities Depository Limited (NSDL), the authorized agency to provide e-voting facilities, engaged by the Company. 3. Further to the above, I submit my report as under:- (i) The e-voting period commenced on Wednesday, 23rd September, 2026 (9.00 a.m.) and ended on Friday, 25th September, 2026 (5.00 p.m.) (ii) The votes cast electronically were unblocked on Saturday, 26th September, 2026 in the presence of 2 witnesses, Mr. Darshan Mehta and Ms. Celina Ambrose. They have signed below in confirmation of the votes being unblocked in their presence, Mr. Darshan Mehta Ms. Celina Ambrose Page 1of3 Thereafter, the details containing inter alia, list of Equity Share Holders, who voted "for'', "against" each of the resolution that were put to vote, were generated from thee-voting website of National Securities Depository Limited (NSDL) i.e. https://www.evoting.nsdl.com and based on such reports generated, the result of thee-voting is as under: The result of the e-voting are as under: Resoluti Particulars Shares Votes casted in Total Votes Votes casted on held Casted Invalid Favour Against % For % Against 1 To receive, consider and adopt the 91270000 0 67544222 593 67544815 99.999% 0.001% ', Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors' and the Auditors thereon. 2 Approval to the Retirement of Shri 91270000 0 67557332 4850 67562182 99.993% 0.007% Uday M. Patil (DIN: 01186406) who retires by rotation and has not offered himself for re-appointment as a Director of the Company. 3 Appointment of Shri Nilesh 91270000 0 67556871 5311 67562182 99.992% 0.008% Bhalchandra Patil (DIN: 08616943) as the Director of the Company. 4. Appointment of Shri Nilesh 91270000 0 67556871 5311 67562182 99.992% 0.008% Bhalchandra Patil (DIN: 08616943) as the Whole-time Director of the Company. 5. Appointment of Shri Adhish Prakash 91270000 0 67548645 13537 67562182 99.980% 0.020% Patil (DIN: 02629496) as the Director of the Company. 6. Appointment of Shri Adhish Prakash 91270000 0 67467785 94397 67562182 99.860% 0.140% Patil (DIN: 02629496) as the Managing Director of the Company. 7. Re-appointment of Shri Harsh it 91270000 0 67440440 121742 67562182 99.820% 0.180% Manilal Savla (DIN: 00005340) as the Joint Managing Director of the Company. 8. Re-appointment of Shri Harit Pragji 91270000 0 67440442 121740 67562182 99.820% 0.180% Shah (DIN: 00005501) as the Whole- time Director of the Company. 9. Re-appointment of Shri Hasmukh 91270000 0 67501119 61063 67562182 99.910% 0.090% Bhavanji Dedhia (DIN: 07510925) as an Independent Director of the Company for the second term of 5 (five) years. '. 10. Re-appointment of Shri San deep 91270000 0 67529065 33117 67562182 99.951% 0.049% Madhusudan Joshi (DIN: 00516409) as an Independent Director of the Company for the second term of 5 (five) years. Page 2 of 3 11. Re-appointment of Shri Ajit Eledath 91270000 0 67502317 59865 67562182 99.911% 0.089% Venugopalan {DIN: 09439069) as an Independent Director of the Company for the second term of 5 (five) years. 12. Approval to Shri Prakash Moreshwar 91270000 0 51963641 1140596 53104237 97.852% 2.148% Patil, a Related Party, to hold an Office or Place of Profit in the Company. 13. Payment of Profit Related Commission 91270000 0 67556759 5423 67562182 99.992% 0.008% to the Non-executive Directors. 14. 'Aarti Drugs Limited Performance 91270000 0 57284494 10277688 67562182 84.788% 15.212% Stock Option Plan 2026' {'PSOP 2026'). 15. Grant of stock options under "Aarti 91270000 0 57284204 10277978 67562182 84.787% 15.213% Drugs Limited Performance Stock Option Plan 2026" {'PSOP 2026'} to the Employees of the Subsidiary Companies, Group Companies and Associate Companies {Present or Future). 16. Ratification of remuneration of Cost 91270000 0 67557019 5163 67562182 99.992% 0.008% Auditors for FY 2026-27. Based on the aforesaid results, all the resolutions as set out in the Notice have been passed with requisite majority, as Ordinary or Special Resolutions, as applicable under the Companies Act 2013. All electronic data and relevant records of e-voting have been handed over to the Company Secretary for safe keeping. Thanking You Yours Faithfully, For Mehta & Mehta, Unique Code No.: P1996MH007500 Company Secretaries, CS Monali Bhandari Partner UDIN: A027091H001619594 Place: Mumbai Date: 261 h September, 2026 Page 3 of 3 COMPANY SECRETARIES 201-206, Shiv Smriti Chambers, 2nd Floor, 49/A, Dr. Annie Besant Road, Above Corporation Bank, Worli, Mumbai-400 018 Tel.: +91-22-6611 9696. •E-mail [Showing first 8,000 characters — download PDF for full document]